Such a tumor-promoting role can be explained by the role of IL-17 in driving inflammation, angiogenesis and tumor growth, and studies so far have indeed described correlations between IL-17 and poor survival in cancer patients [27]. This evidence concerns the gene IL17A and neoplasm.